115 results on '"Stefanski, Adam"'
Search Results
2. Abstract 14549: Body Mass Index Shift and Associated Cardiometabolic Risk Factors in People With Obesity or Overweight: A Post Hoc Analysis From SURMOUNT-1
3. Abstract 14462: Baseline Characteristics of Tirzepatide-Treated Participants Who Shifted to a Normal Body Mass Index (<25 kg/m2): A Post Hoc Analysis From SURMOUNT-1
4. Phosphorus fertiliser value of sewage sludge ash applied to soils differing in phosphate buffering and phosphate sorption capacity
5. #1696673 Weight reduction over time in tirzepatide-treated participants by early weight loss response – post hoc analysis in SURMOUNT-1
6. #1704142 Evaluating the Association Between Early Body Weight Changes with Tirzepatide and Categorical Weight Reduction in People with Obesity or Overweight: a Post-Hoc Analysis
7. Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy
8. Abstract 10370: Effects of Tirzepatide on 24-Hour Ambulatory Blood Pressure and Heart Rate in Adults With Obesity - Results From the SURMOUNT-1 Ambulatory Blood Pressure Monitoring Sub-Study
9. Abstract 14462: Baseline Characteristics of Tirzepatide-Treated Participants Who Shifted to a Normal Body Mass Index (<25 kg/m 2 ): A Post Hoc Analysis From SURMOUNT-1
10. OR10-05 Improved Mental And Psychosocial Patient-Reported Outcomes Among People With Obesity Treated With Tirzepatide: Results From SURMOUNT-1 Study
11. SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
12. SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial
13. Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis.
14. Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial
15. Differences in nutrient foraging among Trifolium subterraneum cultivars deliver improved P-acquisition efficiency
16. Abstract #1395974: Achieving Waist Circumference Targets with Once Weekly Tirzepatide for the Treatment of Obesity
17. Tirzepatide reduces body weight across body mass index (BMI) categories: A SURMOUNT-1 pre-specified analysis
18. Growth and root dry matter allocation by pasture legumes and a grass with contrasting external critical phosphorus requirements
19. Rhizosphere carboxylates and morphological root traits in pasture legumes and grasses
20. Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison.
21. Variation in flowering time and flowering date stability within a cultivar of French serradella.
22. Hard seed breakdown patterns of serradella (Ornithopus spp.) in two contrasting environments of south-eastern Australia.
23. Tirzepatide Once Weekly for the Treatment of Obesity
24. Hard seed breakdown patterns of serradella (Ornithopus spp.) in two contrasting environments of south-eastern Australia
25. Health state utilities associated with weight loss in type 2 diabetes and obesity
26. Critical phosphorus requirements ofTrifoliumspecies: The importance of root morphology and root acclimation in response to phosphorus stress
27. 0620 Effect of Tirzepatide on Weight Loss in Patients with Obstructive Sleep Apnea and Obesity from SURMOUNT-1
28. Health state utilities associated with weight loss in type 2 diabetes and obesity
29. Characterization of people achieving different weight reduction categories with tirzepatide.
30. Critical phosphorus requirements of Trifolium species: The importance of root morphology and root acclimation in response to phosphorus stress.
31. EGF and TGF-beta regulate neutral endopeptidase expression in renal vascular smooth muscle cells
32. Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases
33. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex
34. Field benchmarking of the critical external phosphorus requirements of pasture legumes for southern Australia
35. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis
36. Endocrine disturbances of calcium metabolism in uremia: Renal causes and systemic consequences
37. Complementary phosphorus acquisition strategies of interplanted subterranean clover and white lupin increase sward yield in a low phosphorus soil
38. Direct recovery of 33 P-labelled fertiliser phosphorus in subterranean clover ( Trifolium subterraneum ) pastures under field conditions – The role of agronomic management
39. Effect of Tirzepatide on Kidney Function in People with Excess Body Weight: A Post Hoc Analysis of the SURMOUNT-1 Trial
40. High variation in the percentage of root length colonised by arbuscular mycorrhizal fungi among 139 lines representing the species subterranean clover ( Trifolium subterraneum )
41. Root morphological traits that determine phosphorus-acquisition efficiency and critical external phosphorus requirement in pasture species
42. Rhizosphere carboxylates and morphological root traits in pasture legumes and grasses
43. Management of soil phosphorus fertility determines the phosphorus budget of a temperate grazing system and is the key to improving phosphorus efficiency
44. Differences in nutrient foraging among <italic>Trifolium subterraneum</italic> cultivars deliver improved P-acquisition efficiency.
45. Characterization of radiowave propagation in indoor industrial environments
46. Lack of Association between the Pro12Ala Polymorphism in PPAR-γ2 Gene and Body Weight Changes, Insulin Resistance and Chronic Diabetic Complications in Obese Patients with Type 2 Diabetes
47. Prescription of Calcium Concentration and Pth Control
48. The role of the parathyroid glands in the uremic syndrome
49. EGF and TGF-... regulate neutral endopeptidase expression in renal vascular smooth muscle cells.
50. EGF and TGF-beta regulate neutral and endopeptidase expression in renal vascular smooth muscle...
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.